REQUEST A DEMO
Total
USD $0.00
Search more companies

Nucleus Medisurge Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Nucleus Medisurge Private Limited Profile Updated: November 29, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Nucleus Medisurge Private Limited is an unlisted company, incorporated on 04/03/2015. It has its registered office in the State of PN, India. Company's corporate identification number (CIN) is U24233PN2015PTC154240 and registration number is 154240.

Legal Address
Shop No. 25, Wing E, Kunal Plaza, S. No. 244/A/1, Chinchwad,
Pune; Maharashtra; Postal Code: 411019

Contact Details: Purchase the Nucleus Medisurge Private Limited report to view the information.

Basic Information
Outstanding Shares:
Purchase the Nucleus Medisurge Private Limited report to view the information.
Registered Capital:
Purchase the Nucleus Medisurge Private Limited report to view the information.
Incorporation Date:
March 04, 2015
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Company Performance
Financial values in the chart are available after Nucleus Medisurge Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
17.06%
Total operating revenue
17.07%
Operating profit (EBIT)
-2.68%
EBITDA
17.59%
Net Profit (Loss) for the Period
9.68%
Total assets
2.43%
Total equity
12.4%
Operating Profit Margin (ROS)
-0.77%
Net Profit Margin
-0.19%
Return on Equity (ROE)
-0.28%
Debt to Equity Ratio
-11.05%
Quick Ratio
0.16%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?